{"nctId":"NCT00875394","briefTitle":"Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)","startDateStruct":{"date":"2007-02-01","type":"ACTUAL"},"conditions":["Diabetes Mellitus, Non-Insulin-Dependent"],"count":68,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: sitagliptin phosphate","Drug: Comparator: metformin"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: metformin","Drug: Comparator: Antidiabetic Standard of Care"]},{"label":"3","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: metformin"]}],"interventions":[{"name":"sitagliptin phosphate","otherNames":["sitagliptin"]},{"name":"Comparator: metformin","otherNames":["metformin"]},{"name":"Comparator: metformin","otherNames":["metformin"]},{"name":"Comparator: Antidiabetic Standard of Care","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient Has Type 2 Diabetes Mellitus\n* Patient Is 30-78 Years Of Age On The Day Of Signing Informed Consent\n* Patient Is Currently On Metformin Therapy (1500 Mg/Day)\n* Patient Is A Male Or A Female Who Is Unlikely To Conceive, As Indicated By At Least One Yes Answer To The Following Questions: A) Patient Is A Male. B) Patient Is A Surgically Sterilized Female. C) Patient Is A Postmenopausal Female 45 Years Of Age With \\>2 Years Since Last Menses. D) Patient Is A Non-Sterilized Premenopausal Female And Agrees To Use An Adequate Method Of Contraception To Prevent Pregnancy Throughout The Study Starting With Visit 1 And For 14 Days After The Last Dose Of Study Medication\n* Patient Understands The Study Procedures, The Alternative Treatments Available, The Risks Involved In The Study And Voluntarily Agrees To Participate By Giving Written Informed Consent\n* Patient Has An A1c of 6.5 % - 11.0%\n\nExclusion Criteria:\n\n* Patient Has A History Of Type 1 Diabetes Mellitus Or History Of Ketoacidosis","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"78 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Glycosylated Hemoglobin A1C (A1C) at Week 24","description":"Week 24 A1C minus baseline (Week 0) A1C. The unit for A1C is \"percent\". Thus, this measure represents a difference of percent values.","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":36},"commonTop":["Nausea","Cough"]}}}